FRA:DAN (Denmark)
Â
Unit (5 Ordinary shares & 2 Wrts)
€
0.00
(0%)
Jan 10
Business Description
DanCann Pharma AS
ISIN : DK0061410487
Share Class Description:
FRA:DAN: Unit (5 Ordinary shares & 2 Wrts)Compare
Compare
Traded in other countries / regions
DANCAN.SwedenDAN.GermanyDCPXF.USA IPO Date
2021-05-04Description
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | -0.89 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -9 | |||||
| Beneish M-Score | -17.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 28.1 | |||||
| 3-Year EPS without NRI Growth Rate | -3.1 | |||||
| 3-Year FCF Growth Rate | 53.1 | |||||
| 3-Year Book Growth Rate | -67.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.16 | |||||
| 9-Day RSI | 33.05 | |||||
| 14-Day RSI | 30.95 | |||||
| 6-1 Month Momentum % | -75 | |||||
| 12-1 Month Momentum % | -75.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.26 | |||||
| Quick Ratio | 1.24 | |||||
| Cash Ratio | 0.08 | |||||
| Days Inventory | 8.53 | |||||
| Days Sales Outstanding | 139.18 | |||||
| Days Payable | 61.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -81.5 | |||||
| Shareholder Yield % | 17.16 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -9.71 | |||||
| Operating Margin % | -118.5 | |||||
| Net Margin % | -701.19 | |||||
| FCF Margin % | -61.31 | |||||
| ROE % | -309.29 | |||||
| ROA % | -213.24 | |||||
| ROIC % | -34.66 | |||||
| 3-Year ROIIC % | 275.14 | |||||
| ROC (Joel Greenblatt) % | -1136.1 | |||||
| ROCE % | -285.45 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.24 | |||||
| PB Ratio | 0.27 | |||||
| EV-to-EBIT | -0.17 | |||||
| EV-to-EBITDA | -1.42 | |||||
| EV-to-Revenue | 1.13 | |||||
| EV-to-FCF | -1.84 | |||||
| Earnings Yield (Greenblatt) % | -588.24 | |||||
| FCF Yield % | -53.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DanCann Pharma AS Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.114 | ||
| EPS (TTM) (€) | -0.015 | ||
| Beta | 2.21 | ||
| Volatility % | 221.23 | ||
| 14-Day RSI | 30.95 | ||
| 14-Day ATR (€) | 0.000019 | ||
| 20-Day SMA (€) | 0.00023 | ||
| 12-1 Month Momentum % | -75.67 | ||
| 52-Week Range (€) | 0.0002 - 0.0078 | ||
| Shares Outstanding (Mil) | 3,991.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DanCann Pharma AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DanCann Pharma AS Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
DanCann Pharma AS Frequently Asked Questions
What is DanCann Pharma AS(FRA:DAN)'s stock price today?
The current price of FRA:DAN is €0.00. The 52 week high of FRA:DAN is €0.01 and 52 week low is €0.00.
When is next earnings date of DanCann Pharma AS(FRA:DAN)?
The next earnings date of DanCann Pharma AS(FRA:DAN) is 2025-02-28 Est..
Does DanCann Pharma AS(FRA:DAN) pay dividends? If so, how much?
DanCann Pharma AS(FRA:DAN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers